Conflict of Interest Disclosure

Weight Loss Surgery Guide is owned and published by Cyntar S.C.. Cyntar S.C. operates Hospital Cyntar and is the legal personal-data controller for the website. Lic. Jorge Arriaga is the legal representative of Cyntar S.C..

Obesity Control Center, or OCC, is the bariatric medical practice and patient-facing clinical brand promoted on this website. OCC services are delivered through Hospital Cyntar and its authorized clinical and patient-support personnel.

Weight Loss Surgery Guide compares bariatric providers while being owned by Cyntar S.C., which operates Hospital Cyntar and supports the OCC practice included in those comparisons. The website is therefore not financially or operationally independent from Hospital Cyntar or OCC. Readers should consider this relationship when evaluating rankings, comparisons, featured placements, and descriptions of competing providers.

Cyntar S.C. may receive direct financial benefit when a visitor chooses a consultation, hospital service, procedure, travel program, or other service provided through Hospital Cyntar or OCC. This potential benefit exists even though the website does not charge a separate referral fee.

Surgery inquiries are received and managed only by authorized Hospital Cyntar personnel. Weight Loss Surgery Guide does not sell leads or route them to outside hospitals, brokers, unrelated coordinators, manufacturers, financing companies, or competing providers.

Weight Loss Surgery Guide does not receive referral fees, lead fees, or commissions from outside providers. Provider listings and rankings are not sold as pay-to-play placements. If that practice changes, paid placement must be clearly labeled and this disclosure must be updated before publication.

GT Metabolic Solutions is associated with the MAGDI™ magnetic compression anastomosis technology discussed in connection with Sleeve Plus™ or magnetic metabolic procedures. As of July 22, 2026, Cyntar S.C. and Weight Loss Surgery Guide have no ownership, funding, sponsorship, consulting, referral-fee, royalty, commission, paid educational, or paid editorial relationship with GT Metabolic Solutions. GT Metabolic Solutions does not own, fund, control, or approve the site’s content.

Weight Loss Surgery Guide does not currently publish sponsored manufacturer content, paid third-party educational material, or third-party display advertisements. Cyntar S.C. may purchase external advertising on Google, Meta, or other platforms to direct visitors to this website.

Comparisons must use a documented methodology and distinguish independently verifiable information from provider-supplied claims. Cyntar S.C.’s ownership and financial interest must not be omitted from pages that rank or compare Hospital Cyntar or OCC with competing providers. Material limitations, missing information, and the review date must be disclosed.

Editorial decisions, source selection, evidence grading, risk disclosure, and corrections should follow the published editorial and medical-review process. Commercial benefit must not determine whether known limitations, risks, conflicts, or contrary evidence are disclosed.

Authors and medical reviewers must disclose relevant ownership, employment, consulting, research support, speaking fees, travel support, training roles, referral interests, and other professional or financial relationships. A reviewer’s employment by or ownership interest in OCC, Cyntar S.C., or an affiliated clinical program must be disclosed.

The Ariel Center is not identified in this legal framework as an owner, publisher, data controller, or recipient of Weight Loss Surgery Guide leads. If the website continues to promote or link to Ariel Center services, the relevant page must accurately describe the relationship and any potential financial benefit. Existing language identifying The Ariel Center as a co-publisher must be removed unless that status is separately confirmed and approved.

The website must distinguish authorization or clearance of a device function from approval of a procedure as a treatment for obesity, metabolic disease, or diabetes. Content must not claim that a technology cures or reverses diabetes, guarantees remission, or produces established long-term outcomes when the evidence does not support that conclusion.

Material errors, new financial relationships, sponsored arrangements, referral programs, and newly identified conflicts must be disclosed promptly. Questions may be sent to legal@weightlosssurgeryguide.com.

This disclosure will be reviewed at least every six months and whenever ownership, provider relationships, advertising, sponsorship, referral compensation, editorial leadership, or reviewer relationships change.

legal@weightlosssurgeryguide.com